Details of the Drug
General Information of Drug (ID: DMI9YGU)
| Drug Name |
2-Amino-4,6-diphenyl-pyrimidine
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
4,6-diphenylpyrimidin-2-amine; 40230-24-8; 2-Amino-4,6-diphenylpyrimidine; 4,6-diphenyl-2- Pyrimidinamine; 4,6-Diphenyl-2-pyrimidinamine; CHEMBL261185; KZUCBEYDRUCBCS-UHFFFAOYSA-N; 2-Pyrimidinamine, 4,6-diphenyl-; AK136264; AC1LDIBD; Cambridge id 5109412; AC1Q52JN; CBDivE_006411; MLS001162904; SCHEMBL4904514; 4,6-Diphenylpyrimidine-2-amine; CTK1D4711; DTXSID20347207; MolPort-001-847-654; HMS2833A20; HMS1577A06; 4,6-Diphenyl-2-pyrimidinamine #; ZINC295268; KS-00001N3D; BDBM50375490; AKOS010263933; (4,6-diphenyl-pyrimidin-2-yl)-amine
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 247.29 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.2 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||


